Cingulate Inc. ( CING) - Stock Earnings
CING Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 18, 2026, midnight | — / — | — | — / — | — |
CING Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -7.3 million USD | — USD |
| 2025Q4 | -6.5 million USD | — USD |
| 2026Q1 | -9.3 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
CING Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -23.5 million USD | — USD |
| 2024 | -15.5 million USD | — USD |
| 2025 | -22.5 million USD | — USD |
| 2026 Est. | — | — |
CING
Price: $5.27
52 week price:
Earnings Per Share: -4.33 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 16900
Market Capitalization: 27.1 million